Larimar Therapeutics Inc (LRMR) — Cash Flow Reinvestment Rate
Latest as of December 2017:
0.00x
Larimar Therapeutics Inc (LRMR) has a Cash Flow Reinvestment Rate of 0.00x as of December 2017, reinvesting $10.00K (capex $10.00K ) from operating cash flow of $11.68 Million. Check cash flow quality index of Larimar Therapeutics Inc to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$10.00K
Capex + Investments
Operating Cash Flow
$11.68 Million
USD
Capital Expenditures
$10.00K
USD
Annual Cash Flow Reinvestment Rate for Larimar Therapeutics Inc (None–None)
Year-by-year capital reinvestment analysis for Larimar Therapeutics Inc. For live market cap and broader valuation context, see Larimar Therapeutics Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow